Graffinity AG, a specialist in preclinical drug discovery, landed a commitment from Serono SA to help fill the development pipeline of Europe's largest biotechnology company. (BioWorld Today)
Graffinity AG, a specialist in preclinical drug discovery, landed a commitment from Serono SA to help fill the development pipeline of Europe's largest biotechnology company. (BioWorld Today)
Cellzome AG bucked the gloomy venture market and raised €30 million in its third round of financing. The company, spun off from the European Molecular Biology Laboratory in Heidelberg in May 2000, aims to speed and streamline drug discovery through better understanding the role of cellular pathways in human diseases. (BioWorld Today)
